Changes in quality of life, depression, general anxiety, and heart-focused anxiety after defibrillator implantation.
General anxiety
Heart failure
Heart-focused anxiety
Implantable cardioverter defibrillator
Implantation
Quality of life
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
15
04
2021
received:
13
05
2020
accepted:
30
04
2021
pubmed:
29
5
2021
medline:
29
10
2021
entrez:
28
5
2021
Statut:
ppublish
Résumé
The Anxiety-CHF (Anxiety in patients with Chronic Heart Failure) study investigated heart-focused anxiety (HFA, with the dimensions fear, attention, and avoidance of physical activity), general anxiety, depression, and quality of life (QoL) in patients with heart failure. Psychological measures were assessed before and up to 2 years after the implantation of an implantable cardioverter defibrillator (ICD) with or without cardiac resynchronization therapy defibrillator (CRT-D). One hundred thirty-two patients were enrolled in this monocentric prospective study (44/88 CRT-D/ICD, mean age 61 ± 14 years, mean left ventricular ejection fraction 31 ± 9%, and 29% women). Psychological assessment was performed before device implantation as well as after 5, 12, and 24 months. After device implantation, mean total HFA, HFA-fear, HFA-attention, general anxiety, and QoL improved significantly. Depression and HFA-related avoidance of physical activity did not change. CRT-D patients compared with ICD recipients and women compared with men reported worse QoL at baseline. Younger patients (<median of 63 years) had higher levels of general anxiety and lower levels of HFA-avoidance at baseline than older patients. After 24 months, groups no longer differed from each other on these scores. Patients with a history of shock or anti-tachycardia pacing (shock/ATP; N = 19) reported no improvements in psychological measures and had significantly higher total HFA and HFA-avoidance levels after 2 years than participants without shock/ATP. Anxiety and QoL improved after device implantation, and depression and HFA-avoidance remained unchanged. HFA may be more pronounced after shock/ATP. Psychological counselling in these patients to reduce HFA and increase physical activity should be considered.
Identifiants
pubmed: 34047078
doi: 10.1002/ehf2.13416
pmc: PMC8318491
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2502-2512Informations de copyright
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Psychosomatics. 2009 Sep-Oct;50(5):483-92
pubmed: 19855034
Europace. 2012 Nov;14(11):1602-7
pubmed: 23104857
Eur J Cardiovasc Nurs. 2017 Dec;16(8):742-752
pubmed: 28613082
J Psychosom Res. 2019 May;120:39-45
pubmed: 30929706
Clin Res Cardiol. 2019 Nov;108(11):1175-1196
pubmed: 31076853
Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:6242-6
pubmed: 19965089
Clin Res Cardiol. 2012 Feb;101(2):109-16
pubmed: 22015615
ESC Heart Fail. 2021 Aug;8(4):2502-2512
pubmed: 34047078
Eur Heart J. 2015 Nov 1;36(41):2793-2867
pubmed: 26320108
Psychother Psychosom. 1996;65(1):49-56
pubmed: 8838697
Am Heart J. 2017 Jul;189:75-84
pubmed: 28625384
Heart Lung. 2013 Mar-Apr;42(2):105-11
pubmed: 23110854
Psychosom Med. 2013 Jan;75(1):36-41
pubmed: 23197843
Am J Crit Care. 2006 Jul;15(4):389-98
pubmed: 16823016
Int J Psychiatry Med. 2012;43(4):349-64
pubmed: 23094467
J Psychosom Res. 2014 Aug;77(2):122-7
pubmed: 25077853
J Arrhythm. 2016 Feb;32(1):1-28
pubmed: 26949427
J Psychosom Res. 2011 Aug;71(2):74-8
pubmed: 21767686
Eur Heart J. 2017 Jun 7;38(22):1738-1746
pubmed: 28329280
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Eur Heart J. 2021 Jan 1;42(1):17-96
pubmed: 32860412
Europace. 2019 Jun 1;21(6):900-908
pubmed: 30796456
J Psychosom Res. 2011 Oct;71(4):223-31
pubmed: 21911099
Heart Vessels. 2014 May;29(3):364-74
pubmed: 23732755
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Rehabil Med. 2016 Mar;48(3):300-6
pubmed: 26667151
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Europace. 2020 Dec 23;22(12):1830-1840
pubmed: 33106878
Mayo Clin Proc. 2005 Feb;80(2):232-7
pubmed: 15704778
Heart Fail Rev. 2016 Jan;21(1):49-63
pubmed: 26572543
JAMA Intern Med. 2013 Apr 8;173(7):571-7
pubmed: 23420455
J Am Coll Cardiol. 2006 Oct 17;48(8):1527-37
pubmed: 17045884
JACC Clin Electrophysiol. 2017 Feb;3(2):117-126
pubmed: 29759383
CJC Open. 2020 Jun 16;2(6):483-489
pubmed: 33305207
J Affect Disord. 2020 Nov 1;276:380-387
pubmed: 32871668
Heart Lung. 2005 Sep-Oct;34(5):299-308
pubmed: 16157184
Heart Lung. 2004 May-Jun;33(3):176-82
pubmed: 15136777
BMC Health Serv Res. 2013 Oct 09;13:403
pubmed: 24107009
Clin Res Cardiol. 2016 Mar;105(3):216-24
pubmed: 26481915
Eur Heart J. 2020 Mar 14;41(11):1203-1211
pubmed: 30957867
J Psychosom Res. 2020 Feb 11;131:109958
pubmed: 32120145
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):676-86
pubmed: 17001205
Behav Res Ther. 2000 Oct;38(10):1039-53
pubmed: 11004742
Behav Res Ther. 1992 Jul;30(4):329-45
pubmed: 1616469
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):818-25
pubmed: 17001224
Europace. 2008 May;10(5):545-51
pubmed: 18378633